Ideation and assessment of a nitric oxide delivery system for spontaneously breathing subjects
There is an increasing interest in safely delivering high dose of inhaled nitric oxide (NO) as an antimicrobial and antiviral therapeutics for spontaneously breathing patients. A novel NO delivery system is described. We developed a gas delivery system that utilizes standard respiratory circuit conn...
Saved in:
Published in | Nitric oxide Vol. 104-105; pp. 29 - 35 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Elsevier Inc
01.11.2020
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | There is an increasing interest in safely delivering high dose of inhaled nitric oxide (NO) as an antimicrobial and antiviral therapeutics for spontaneously breathing patients. A novel NO delivery system is described.
We developed a gas delivery system that utilizes standard respiratory circuit connectors, a reservoir bag, and a scavenging chamber containing calcium hydroxide. The performance of the system was tested using a mechanical lung, assessing the NO concentration delivered at varying inspiratory flows. Safety was assessed in vitro and in vivo by measuring nitrogen dioxide (NO2) levels in the delivered NO gas. Lastly, we measured the inspired and expired NO and NO2 of this system in 5 healthy subjects during a 15-min administration of high dose NO (160 parts-per-million, ppm) using our delivery system.
The system demonstrated stable delivery of prescribed NO levels at various inspiratory flow rates (0–50 L/min). The reservoir bag and a high flow of entering air minimized the oscillation of NO concentrations during inspiration on average 4.6 ppm for each 10 L/min increment in lung inspiratory flow.
The calcium hydroxide scavenger reduced the inhaled NO2 concentration on average 0.9 ppm (95% CI -1.58, −0.22; p = .01). We performed 49 NO administrations of 160 ppm in 5 subjects. The average concentration of inspired NO was 164.8±10.74 ppm, with inspired NO2 levels of 0.7±0.13 ppm. The subjects did not experience any adverse events; transcutaneous methemoglobin concentrations increased from 1.05±0.58 to 2.26±0.47%.
The system we developed to administer high-dose NO for inhalation is easy to build, reliable, was well tolerated in healthy subjects.
•We conceived and tested a NO delivery system for spontaneously breathing subjects.•A scavenger containing calcium hydroxide reduces the inspired NO2 concentration.•A reservoir bag reduces variations of NO concentration during breathing.•In five healthy subjects breathing 164.8±10.74 ppm of NO, inspired NO2 was 0.7±0.13 ppm.•In a healthy subject breathing 153 ppm of NO, the exhaled NO2 was 0.03 ppm. |
---|---|
AbstractList | •
We conceived and tested a NO delivery system for spontaneously breathing subjects.
•
A scavenger containing calcium hydroxide reduces the inspired NO
2
concentration.
•
A reservoir bag reduces variations of NO concentration during breathing.
•
In five healthy subjects breathing 164.8
±
10.74 ppm of NO, inspired NO
2
was 0.7
±
0.13 ppm.
•
In a healthy subject breathing 153 ppm of NO, the exhaled NO
2
was 0.03 ppm. There is an increasing interest in safely delivering high dose of inhaled nitric oxide (NO) as an antimicrobial and antiviral therapeutics for spontaneously breathing patients. A novel NO delivery system is described. We developed a gas delivery system that utilizes standard respiratory circuit connectors, a reservoir bag, and a scavenging chamber containing calcium hydroxide. The performance of the system was tested using a mechanical lung, assessing the NO concentration delivered at varying inspiratory flows. Safety was assessed in vitro and in vivo by measuring nitrogen dioxide (NO ) levels in the delivered NO gas. Lastly, we measured the inspired and expired NO and NO of this system in 5 healthy subjects during a 15-min administration of high dose NO (160 parts-per-million, ppm) using our delivery system. The system demonstrated stable delivery of prescribed NO levels at various inspiratory flow rates (0-50 L/min). The reservoir bag and a high flow of entering air minimized the oscillation of NO concentrations during inspiration on average 4.6 ppm for each 10 L/min increment in lung inspiratory flow. The calcium hydroxide scavenger reduced the inhaled NO concentration on average 0.9 ppm (95% CI -1.58, -0.22; p = .01). We performed 49 NO administrations of 160 ppm in 5 subjects. The average concentration of inspired NO was 164.8±10.74 ppm, with inspired NO levels of 0.7±0.13 ppm. The subjects did not experience any adverse events; transcutaneous methemoglobin concentrations increased from 1.05±0.58 to 2.26±0.47%. The system we developed to administer high-dose NO for inhalation is easy to build, reliable, was well tolerated in healthy subjects. There is an increasing interest in safely delivering high dose of inhaled nitric oxide (NO) as an antimicrobial and antiviral therapeutics for spontaneously breathing patients. A novel NO delivery system is described.BACKGROUNDThere is an increasing interest in safely delivering high dose of inhaled nitric oxide (NO) as an antimicrobial and antiviral therapeutics for spontaneously breathing patients. A novel NO delivery system is described.We developed a gas delivery system that utilizes standard respiratory circuit connectors, a reservoir bag, and a scavenging chamber containing calcium hydroxide. The performance of the system was tested using a mechanical lung, assessing the NO concentration delivered at varying inspiratory flows. Safety was assessed in vitro and in vivo by measuring nitrogen dioxide (NO2) levels in the delivered NO gas. Lastly, we measured the inspired and expired NO and NO2 of this system in 5 healthy subjects during a 15-min administration of high dose NO (160 parts-per-million, ppm) using our delivery system.METHODSWe developed a gas delivery system that utilizes standard respiratory circuit connectors, a reservoir bag, and a scavenging chamber containing calcium hydroxide. The performance of the system was tested using a mechanical lung, assessing the NO concentration delivered at varying inspiratory flows. Safety was assessed in vitro and in vivo by measuring nitrogen dioxide (NO2) levels in the delivered NO gas. Lastly, we measured the inspired and expired NO and NO2 of this system in 5 healthy subjects during a 15-min administration of high dose NO (160 parts-per-million, ppm) using our delivery system.The system demonstrated stable delivery of prescribed NO levels at various inspiratory flow rates (0-50 L/min). The reservoir bag and a high flow of entering air minimized the oscillation of NO concentrations during inspiration on average 4.6 ppm for each 10 L/min increment in lung inspiratory flow. The calcium hydroxide scavenger reduced the inhaled NO2 concentration on average 0.9 ppm (95% CI -1.58, -0.22; p = .01). We performed 49 NO administrations of 160 ppm in 5 subjects. The average concentration of inspired NO was 164.8±10.74 ppm, with inspired NO2 levels of 0.7±0.13 ppm. The subjects did not experience any adverse events; transcutaneous methemoglobin concentrations increased from 1.05±0.58 to 2.26±0.47%.RESULTSThe system demonstrated stable delivery of prescribed NO levels at various inspiratory flow rates (0-50 L/min). The reservoir bag and a high flow of entering air minimized the oscillation of NO concentrations during inspiration on average 4.6 ppm for each 10 L/min increment in lung inspiratory flow. The calcium hydroxide scavenger reduced the inhaled NO2 concentration on average 0.9 ppm (95% CI -1.58, -0.22; p = .01). We performed 49 NO administrations of 160 ppm in 5 subjects. The average concentration of inspired NO was 164.8±10.74 ppm, with inspired NO2 levels of 0.7±0.13 ppm. The subjects did not experience any adverse events; transcutaneous methemoglobin concentrations increased from 1.05±0.58 to 2.26±0.47%.The system we developed to administer high-dose NO for inhalation is easy to build, reliable, was well tolerated in healthy subjects.CONCLUSIONSThe system we developed to administer high-dose NO for inhalation is easy to build, reliable, was well tolerated in healthy subjects. There is an increasing interest in safely delivering high dose of inhaled nitric oxide (NO) as an antimicrobial and antiviral therapeutics for spontaneously breathing patients. A novel NO delivery system is described. We developed a gas delivery system that utilizes standard respiratory circuit connectors, a reservoir bag, and a scavenging chamber containing calcium hydroxide. The performance of the system was tested using a mechanical lung, assessing the NO concentration delivered at varying inspiratory flows. Safety was assessed in vitro and in vivo by measuring nitrogen dioxide (NO2) levels in the delivered NO gas. Lastly, we measured the inspired and expired NO and NO2 of this system in 5 healthy subjects during a 15-min administration of high dose NO (160 parts-per-million, ppm) using our delivery system. The system demonstrated stable delivery of prescribed NO levels at various inspiratory flow rates (0–50 L/min). The reservoir bag and a high flow of entering air minimized the oscillation of NO concentrations during inspiration on average 4.6 ppm for each 10 L/min increment in lung inspiratory flow. The calcium hydroxide scavenger reduced the inhaled NO2 concentration on average 0.9 ppm (95% CI -1.58, −0.22; p = .01). We performed 49 NO administrations of 160 ppm in 5 subjects. The average concentration of inspired NO was 164.8±10.74 ppm, with inspired NO2 levels of 0.7±0.13 ppm. The subjects did not experience any adverse events; transcutaneous methemoglobin concentrations increased from 1.05±0.58 to 2.26±0.47%. The system we developed to administer high-dose NO for inhalation is easy to build, reliable, was well tolerated in healthy subjects. •We conceived and tested a NO delivery system for spontaneously breathing subjects.•A scavenger containing calcium hydroxide reduces the inspired NO2 concentration.•A reservoir bag reduces variations of NO concentration during breathing.•In five healthy subjects breathing 164.8±10.74 ppm of NO, inspired NO2 was 0.7±0.13 ppm.•In a healthy subject breathing 153 ppm of NO, the exhaled NO2 was 0.03 ppm. |
Author | Larson, Grant Gianni, Stefano Zapol, Warren M. Berra, Lorenzo Pinciroli, Riccardo Morais, Caio C.A. Carroll, Ryan Yu, Binglan |
Author_xml | – sequence: 1 givenname: Stefano surname: Gianni fullname: Gianni, Stefano organization: Department of Anaesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA – sequence: 2 givenname: Caio C.A. surname: Morais fullname: Morais, Caio C.A. organization: Department of Anaesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA – sequence: 3 givenname: Grant orcidid: 0000-0003-3308-1591 surname: Larson fullname: Larson, Grant organization: Department of Anaesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA – sequence: 4 givenname: Riccardo orcidid: 0000-0003-2567-1591 surname: Pinciroli fullname: Pinciroli, Riccardo organization: Department of Anaesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA – sequence: 5 givenname: Ryan orcidid: 0000-0002-7513-7023 surname: Carroll fullname: Carroll, Ryan organization: Department of Pediatrics, Massachusetts General Hospital and Harvard Medical School Boston, Massachusetts, USA – sequence: 6 givenname: Binglan surname: Yu fullname: Yu, Binglan organization: Department of Anaesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA – sequence: 7 givenname: Warren M. surname: Zapol fullname: Zapol, Warren M. organization: Department of Anaesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA – sequence: 8 givenname: Lorenzo surname: Berra fullname: Berra, Lorenzo email: lberra@mgh.harvard.edu organization: Department of Anaesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/32835810$$D View this record in MEDLINE/PubMed |
BookMark | eNp9UU1rGzEQFSWlSdz-gR6Kjr14I2m1ay2UQgn9CAR6aa8VWmmUyOxKrkY28b-vXCch7SGnGZj3wbx3Tk5iikDIW84aznh_sW5iSHeNYII1TDWMyRfkjDM1LFXP-cnjztpTco64ZhXRqv4VOW2FajvF2Rn5deXAlJAiNdFRgwiIM8RCk6eGxlBysDTdBQfUwRR2kPcU91hgpj5lipsUi4mQtjjt6Zir1m2INxS34xpswdfkpTcTwpv7uSA_v3z-cfltef3969Xlp-ullV1XlmJgQ-sdjMLDIHrhpTfA7eClktA6aZSxPePdaI1UClzPVp31nXG9XTk1-HZBPh51N9txBmfrB9lMepPDbPJeJxP0v5cYbvVN2umVlHwYhirw_l4gp99bwKLngBam6ficFrJdccFrgBX67qnXo8lDqBWgjgCbE2IGr20of0Ou1mHSnOlDf3qtD_3pQ3-aKX1oZ0HEf9QH9WdJH44kqAnvAmSNNkC04EKuJWiXwnP0P_8NuAU |
CitedBy_id | crossref_primary_10_1097_AOG_0000000000004847 crossref_primary_10_1016_j_niox_2023_05_007 crossref_primary_10_3390_biomedicines10071525 crossref_primary_10_3390_biomedicines10020369 crossref_primary_10_1016_j_ajem_2022_04_052 crossref_primary_10_1016_j_poly_2022_115822 crossref_primary_10_4187_respcare_09308 crossref_primary_10_1371_journal_pone_0258368 crossref_primary_10_3389_fcvm_2024_1374635 crossref_primary_10_1016_j_niox_2024_06_003 crossref_primary_10_1016_j_niox_2021_08_003 crossref_primary_10_1097_CCE_0000000000000277 crossref_primary_10_1007_s11172_024_4454_9 crossref_primary_10_1016_j_virusres_2020_198202 |
Cites_doi | 10.1164/rccm.202005-1906ED 10.1213/ANE.0b013e3181f46da8 10.1093/bja/74.1.107-a 10.1155/2020/1536714 10.1016/j.transproceed.2008.08.124 10.1097/00000542-200611000-00008 10.1016/j.jcf.2013.01.008 10.1016/j.virol.2009.09.007 10.1136/bmjopen-2018-026848 10.1136/ewjm.175.3.193 10.1136/thoraxjnl-2015-208209 10.1128/JVI.79.3.1966-1969.2005 |
ContentType | Journal Article |
Copyright | 2020 Elsevier Inc. Copyright © 2020 Elsevier Inc. All rights reserved. 2020 Elsevier Inc. All rights reserved. 2020 Elsevier Inc. |
Copyright_xml | – notice: 2020 Elsevier Inc. – notice: Copyright © 2020 Elsevier Inc. All rights reserved. – notice: 2020 Elsevier Inc. All rights reserved. 2020 Elsevier Inc. |
DBID | AAYXX CITATION NPM 7X8 5PM |
DOI | 10.1016/j.niox.2020.08.004 |
DatabaseName | CrossRef PubMed MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
DatabaseTitleList | PubMed MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Anatomy & Physiology Chemistry Biology |
EISSN | 1089-8611 |
EndPage | 35 |
ExternalDocumentID | PMC7441999 32835810 10_1016_j_niox_2020_08_004 S1089860320301828 |
Genre | Research Support, Non-U.S. Gov't Journal Article Research Support, N.I.H., Extramural |
GrantInformation_xml | – fundername: NHLBI NIH HHS grantid: R21 HL130956 – fundername: NHLBI NIH HHS grantid: U54 HL119145 – fundername: NHLBI NIH HHS grantid: K23 HL128882 |
GroupedDBID | --- --K --M -~X .~1 0R~ 123 1B1 1RT 1~. 1~5 4.4 457 4G. 5RE 5VS 7-5 71M 8P~ AACTN AAEDT AAEDW AAIKJ AAKOC AALRI AAOAW AAQFI AATTM AAXKI AAXUO ABGSF ABMAC ABUDA ACDAQ ACGFS ACRLP ADBBV ADEZE ADUVX AEBSH AEHWI AEIPS AEKER AFTJW AFXIZ AGHFR AGUBO AGYEJ AIEXJ AIKHN AITUG AKRWK ALMA_UNASSIGNED_HOLDINGS AMRAJ ANKPU AXJTR BKOJK BLXMC BNPGV CS3 DM4 EBS EFBJH EO8 EO9 EP2 EP3 F5P FDB FEDTE FIRID FNPLU FYGXN G-Q GBLVA HVGLF IHE J1W KOM LG5 M41 MO0 N9A O-L O9- OAUVE OZT P-8 P-9 P2P PC. Q38 ROL RPZ SCC SDF SDG SDP SES SPCBC SSH SSU SSZ T5K WH7 ZU3 ~G- .55 .GJ 29N 3O- 53G AAQXK AAYWO AAYXX ABFNM ABWVN ABXDB ACRPL ACVFH ADCNI ADFGL ADMUD ADNMO AEUPX AFJKZ AFPUW AGCQF AGQPQ AGRDE AGRNS AIGII AIIUN AKBMS AKYEP APXCP ASPBG AVWKF AZFZN CAG CITATION COF EJD FGOYB HZ~ H~9 R2- RIG SEW X7M XPP ZGI NPM 7X8 5PM EFKBS |
ID | FETCH-LOGICAL-c455t-29093fdeb2fe9262f4fae1c9f484e3d4a8ac6015bca488ed6075cf5ad6c7d89f3 |
IEDL.DBID | .~1 |
ISSN | 1089-8603 1089-8611 |
IngestDate | Thu Aug 21 13:30:25 EDT 2025 Thu Jul 10 20:05:42 EDT 2025 Thu Apr 03 07:08:28 EDT 2025 Tue Jul 01 03:23:03 EDT 2025 Thu Apr 24 22:55:46 EDT 2025 Sun Apr 06 06:53:53 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Keywords | Delivery system Nitrogen dioxide Nitric oxide |
Language | English |
License | Copyright © 2020 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c455t-29093fdeb2fe9262f4fae1c9f484e3d4a8ac6015bca488ed6075cf5ad6c7d89f3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 These authors contributed equally to this work. |
ORCID | 0000-0002-7513-7023 0000-0003-2567-1591 0000-0003-3308-1591 |
OpenAccessLink | https://pubmed.ncbi.nlm.nih.gov/PMC7441999 |
PMID | 32835810 |
PQID | 2437121043 |
PQPubID | 23479 |
PageCount | 7 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_7441999 proquest_miscellaneous_2437121043 pubmed_primary_32835810 crossref_citationtrail_10_1016_j_niox_2020_08_004 crossref_primary_10_1016_j_niox_2020_08_004 elsevier_sciencedirect_doi_10_1016_j_niox_2020_08_004 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2020-11-01 |
PublicationDateYYYYMMDD | 2020-11-01 |
PublicationDate_xml | – month: 11 year: 2020 text: 2020-11-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | Nitric oxide |
PublicationTitleAlternate | Nitric Oxide |
PublicationYear | 2020 |
Publisher | Elsevier Inc |
Publisher_xml | – name: Elsevier Inc |
References | Feiner, Bickler (bib12) 2010; 111 Akerström, Gunalan, Keng, Tan, Mirazimi (bib3) 2009; 395 Pickett, Mahmood, Latimer, Powroznyk, Ghosh, Oduro (bib10) 1995; 74 Miller, Hergott, Rohan, Arsenault-Mehta, Döring, Mehta (bib15) 2013; 12 Safaee Fakhr, Wiegand, Pinciroli, Gianni (bib18) 2020 Marrazzo, Spina, Zadek (bib8) 2019; 9 (bib14) 2020 Alvarez, Berra, Gladwin (bib19) 2020; 202(1) Barker, Curry, Redford, Morgan (bib13) 2006; 105 Bartley (bib16) 2020 McMullin, Chittock, Roscoe, Garcha, Wang, Miller (bib2) 2005; 50 Davidson, Banham, Elliott (bib11) 2016; 71 Berra, Lei, Su (bib6) 2020 Moreno, Mir, Vicente (bib17) 2008; 40 Lei C, Su B, Dong H, et al. Title: Protocol of a Randomized Controlled Trial Testing Inhaled Nitric Oxide in Mechanically Ventilated Patients with Severe Acute Respiratory Syndrome in COVID-19 (SARS-CoV-2).:16.. Rehman (bib9) 2001; 175 Akerström, Mousavi-Jazi, Klingström, Leijon, Lundkvist, Mirazimi (bib4) 2005; 79 Gianni S, Fakhr BS, Morais CCA, et al. Nitric Oxide Gas Inhalation to Prevent COVID-2019 in Healthcare Providers. :14. bib1 Alvarez (10.1016/j.niox.2020.08.004_bib19) 2020; 202(1) Akerström (10.1016/j.niox.2020.08.004_bib3) 2009; 395 Berra (10.1016/j.niox.2020.08.004_bib6) 2020 Marrazzo (10.1016/j.niox.2020.08.004_bib8) 2019; 9 McMullin (10.1016/j.niox.2020.08.004_bib2) 2005; 50 Moreno (10.1016/j.niox.2020.08.004_bib17) 2008; 40 Akerström (10.1016/j.niox.2020.08.004_bib4) 2005; 79 Davidson (10.1016/j.niox.2020.08.004_bib11) 2016; 71 Miller (10.1016/j.niox.2020.08.004_bib15) 2013; 12 Feiner (10.1016/j.niox.2020.08.004_bib12) 2010; 111 10.1016/j.niox.2020.08.004_bib5 Safaee Fakhr (10.1016/j.niox.2020.08.004_bib18) 2020 Rehman (10.1016/j.niox.2020.08.004_bib9) 2001; 175 Bartley (10.1016/j.niox.2020.08.004_bib16) 2020 Pickett (10.1016/j.niox.2020.08.004_bib10) 1995; 74 10.1016/j.niox.2020.08.004_bib7 Barker (10.1016/j.niox.2020.08.004_bib13) 2006; 105 |
References_xml | – volume: 50 start-page: 6 year: 2005 ident: bib2 article-title: The antimicrobial effect of nitric oxide on the bacteria that cause nosocomial pneumonia in mechanically ventilated patients in the intensive care unit publication-title: Respir. Care – start-page: 136 year: 2020 ident: bib18 article-title: High concentrations of nitric oxide inhalation therapy in pregnant patients with severe coronavirus disease 2019 (COVID-19) publication-title: Obstet. Gynecol. – year: 2020 ident: bib14 article-title: 1988 OSHA PEL project - nitrogen dioxide | NIOSH | CDC [internet] – year: 2020 ident: bib16 article-title: High-dose inhaled nitric oxide as adjunct therapy in cystic fibrosis targeting Burkholderia multivorans publication-title: Case Reports in Pediatrics – volume: 105 start-page: 892 year: 2006 end-page: 897 ident: bib13 article-title: Measurement of carboxyhemoglobin and methemoglobin by pulse oximetry: a human volunteer study publication-title: Anesthesiology – volume: 79 start-page: 1966 year: 2005 end-page: 1969 ident: bib4 article-title: Nitric oxide inhibits the replication cycle of severe acute respiratory syndrome coronavirus publication-title: J. Virol. – year: 2020 ident: bib6 article-title: Protocol for a Randomized Controlled Trial Testing Inhaled Nitric Oxide Therapy in Spontaneously Breathing Patients with COVID-19 [Internet]. Intensive Care and Critical Care Medicine – volume: 71 year: 2016 ident: bib11 article-title: BTS/ICS guideline for the ventilatory management of acute hypercapnic respiratory failure in adults publication-title: Thorax – volume: 40 start-page: 3082 year: 2008 end-page: 3084 ident: bib17 article-title: Analysis of interleukin-6 and interleukin-8 in lung transplantation: correlation with nitric oxide administration publication-title: Transplant. Proc. – volume: 9 year: 2019 ident: bib8 article-title: Protocol of a randomised controlled trial in cardiac surgical patients with endothelial dysfunction aimed to prevent postoperative acute kidney injury by administering nitric oxide gas publication-title: BMJ Open – volume: 202(1) start-page: 16 year: 2020 end-page: 20 ident: bib19 article-title: Home NO therapy for COVID-19 publication-title: Am. J. Respir. Crit. Care Med. – reference: Lei C, Su B, Dong H, et al. Title: Protocol of a Randomized Controlled Trial Testing Inhaled Nitric Oxide in Mechanically Ventilated Patients with Severe Acute Respiratory Syndrome in COVID-19 (SARS-CoV-2).:16.. – volume: 175 start-page: 193 year: 2001 end-page: 196 ident: bib9 publication-title: Methemoglobinemia. West J Med – volume: 12 start-page: 817 year: 2013 end-page: 820 ident: bib15 article-title: Inhaled nitric oxide decreases the bacterial load in a rat model of Pseudomonas aeruginosa pneumonia publication-title: J. Cyst. Fibros. – ident: bib1 article-title: 20845_INOmax_Approv.pdf – volume: 111 start-page: 1160 year: 2010 end-page: 1167 ident: bib12 article-title: Improved accuracy of methemoglobin detection by pulse CO-oximetry during hypoxia publication-title: Anesth. Analg. – volume: 395 start-page: 1 year: 2009 end-page: 9 ident: bib3 article-title: Dual effect of nitric oxide on SARS-CoV replication: viral RNA production and palmitoylation of the S protein are affected publication-title: Virology – reference: Gianni S, Fakhr BS, Morais CCA, et al. Nitric Oxide Gas Inhalation to Prevent COVID-2019 in Healthcare Providers. :14. – volume: 74 start-page: 107 year: 1995 end-page: 108 ident: bib10 article-title: Effective absorption of nitrogen dioxide with soda lime publication-title: Br. J. Anaesth. – volume: 202(1) start-page: 16 year: 2020 ident: 10.1016/j.niox.2020.08.004_bib19 article-title: Home NO therapy for COVID-19 publication-title: Am. J. Respir. Crit. Care Med. doi: 10.1164/rccm.202005-1906ED – volume: 111 start-page: 1160 issue: 5 year: 2010 ident: 10.1016/j.niox.2020.08.004_bib12 article-title: Improved accuracy of methemoglobin detection by pulse CO-oximetry during hypoxia publication-title: Anesth. Analg. doi: 10.1213/ANE.0b013e3181f46da8 – volume: 74 start-page: 107 issue: 1 year: 1995 ident: 10.1016/j.niox.2020.08.004_bib10 article-title: Effective absorption of nitrogen dioxide with soda lime publication-title: Br. J. Anaesth. doi: 10.1093/bja/74.1.107-a – ident: 10.1016/j.niox.2020.08.004_bib5 – year: 2020 ident: 10.1016/j.niox.2020.08.004_bib16 article-title: High-dose inhaled nitric oxide as adjunct therapy in cystic fibrosis targeting Burkholderia multivorans publication-title: Case Reports in Pediatrics doi: 10.1155/2020/1536714 – year: 2020 ident: 10.1016/j.niox.2020.08.004_bib6 – volume: 40 start-page: 3082 issue: 9 year: 2008 ident: 10.1016/j.niox.2020.08.004_bib17 article-title: Analysis of interleukin-6 and interleukin-8 in lung transplantation: correlation with nitric oxide administration publication-title: Transplant. Proc. doi: 10.1016/j.transproceed.2008.08.124 – ident: 10.1016/j.niox.2020.08.004_bib7 – volume: 50 start-page: 6 issue: 11 year: 2005 ident: 10.1016/j.niox.2020.08.004_bib2 article-title: The antimicrobial effect of nitric oxide on the bacteria that cause nosocomial pneumonia in mechanically ventilated patients in the intensive care unit publication-title: Respir. Care – volume: 105 start-page: 892 issue: 5 year: 2006 ident: 10.1016/j.niox.2020.08.004_bib13 article-title: Measurement of carboxyhemoglobin and methemoglobin by pulse oximetry: a human volunteer study publication-title: Anesthesiology doi: 10.1097/00000542-200611000-00008 – volume: 12 start-page: 817 issue: 6 year: 2013 ident: 10.1016/j.niox.2020.08.004_bib15 article-title: Inhaled nitric oxide decreases the bacterial load in a rat model of Pseudomonas aeruginosa pneumonia publication-title: J. Cyst. Fibros. doi: 10.1016/j.jcf.2013.01.008 – volume: 395 start-page: 1 issue: 1 year: 2009 ident: 10.1016/j.niox.2020.08.004_bib3 article-title: Dual effect of nitric oxide on SARS-CoV replication: viral RNA production and palmitoylation of the S protein are affected publication-title: Virology doi: 10.1016/j.virol.2009.09.007 – volume: 9 issue: 7 year: 2019 ident: 10.1016/j.niox.2020.08.004_bib8 article-title: Protocol of a randomised controlled trial in cardiac surgical patients with endothelial dysfunction aimed to prevent postoperative acute kidney injury by administering nitric oxide gas publication-title: BMJ Open doi: 10.1136/bmjopen-2018-026848 – volume: 175 start-page: 193 issue: 3 year: 2001 ident: 10.1016/j.niox.2020.08.004_bib9 publication-title: Methemoglobinemia. West J Med doi: 10.1136/ewjm.175.3.193 – volume: 71 issue: Suppl 2 year: 2016 ident: 10.1016/j.niox.2020.08.004_bib11 article-title: BTS/ICS guideline for the ventilatory management of acute hypercapnic respiratory failure in adults publication-title: Thorax doi: 10.1136/thoraxjnl-2015-208209 – volume: 79 start-page: 1966 issue: 3 year: 2005 ident: 10.1016/j.niox.2020.08.004_bib4 article-title: Nitric oxide inhibits the replication cycle of severe acute respiratory syndrome coronavirus publication-title: J. Virol. doi: 10.1128/JVI.79.3.1966-1969.2005 – start-page: 136 year: 2020 ident: 10.1016/j.niox.2020.08.004_bib18 article-title: High concentrations of nitric oxide inhalation therapy in pregnant patients with severe coronavirus disease 2019 (COVID-19) publication-title: Obstet. Gynecol. |
SSID | ssj0004386 |
Score | 2.3705177 |
Snippet | There is an increasing interest in safely delivering high dose of inhaled nitric oxide (NO) as an antimicrobial and antiviral therapeutics for spontaneously... • We conceived and tested a NO delivery system for spontaneously breathing subjects. • A scavenger containing calcium hydroxide reduces the inspired NO 2... |
SourceID | pubmedcentral proquest pubmed crossref elsevier |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 29 |
SubjectTerms | Analytical Methods Delivery system Nitric oxide Nitrogen dioxide |
Title | Ideation and assessment of a nitric oxide delivery system for spontaneously breathing subjects |
URI | https://dx.doi.org/10.1016/j.niox.2020.08.004 https://www.ncbi.nlm.nih.gov/pubmed/32835810 https://www.proquest.com/docview/2437121043 https://pubmed.ncbi.nlm.nih.gov/PMC7441999 |
Volume | 104-105 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELaqogouCFoey6NyJcQFpZusJw8flxXV9qEKAZV6quX4IYKWpGJ3pe6F385MnCwsVD1wymssWZ6J_Y098w1jbxIwsrDCRklWQgTCjCJpSxs5oBNC8CNjWrbP82x6ASeX6eUWm_S5MBRW2c39YU5vZ-vuzbAbzeF1VQ0_J3Ehi4wKgKORouNAGeyQk5Uf_vwd5gGirfZIwhFJd4kzIcarrpob9BFHcUvj2RVru2Vx-hd8_h1D-ceidPSIPezQJB-HDj9mW67eZXvjGj3p7yv-lrfxne3G-S7bed_f3Z_0Vd722NWxDaiR69pyvebp5I3nmuP_jvMkb24q67h1MwriWPHA_swR7nIKsEV46ZrlfLbiJSFQ2tLi82VJGzzzJ-zi6MOXyTTqai5EBtJ0EY1kLIW36G97R1SCHrx2iZEeCnDCgi60QR8uLYkNvXA2Q8hhfKptZnJbSC-esu26qd1zxhEoydilibalAHSzdCYdIBrIROwyl8OAJf1gK9MRklNdjJnqI8--KVKQIgUpKpYZY5t36zbXgY7jTum016HaMCqF68Wd7Q56hStUBx2hhJFURN9IlGsgBuxZMIB1PwRR1xVJPGD5hmmsBYjJe_NLXX1tGb1zBKWI1F_8Z39fsgf0FFIkX7HtxY-le41YaVHutz_DPrs3nnw6-0jX49Pp-S8cdRes |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwED-NTmh7QbDxUT6NhHhBUZPaSZPHUjG1bPSFTdoTluMPLagk09pK63_PXewUCmgPvEWxT7J8Z_t39t3vAN4lQhe54SZKslJEguthVJjSRFbQC6FwQ61bts95Nr0Qny_Tyz2YdLkwFFYZ9n6_p7e7dfgzCLM5uK6qwdckzos8owLgaKToONyDfWKnSnuwP56dTue_0iN5W_CR-kckEHJnfJhXXTW36CYO45bJM9Rr-8f59Df-_DOM8rdz6eQhPAiAko39mB_Bnq2P4HhcozP9Y8PeszbEs707P4L7H7uvg0lX6O0Yvs2MB45M1YapLVUnaxxTDJc8bpWsua2MZcYuKI5jwzwBNEPEyyjGFhGmbdbLxYaVBELpVost1yXd8Swfw8XJp_PJNAplFyIt0nQVDYu44M6gy-0ssQk64ZRNdOFELiw3QuVKoxuXlkSInluTIerQLlUm0yOTF44_gV7d1PYZMMRKRWzTRJmSC_S0VFZYgYAg47HN7Ej0IekmW-rASU6lMRayCz77LklBkhQkqV5mjDIftjLXnpHjzt5pp0O5Y1cSj4w75d52CpeoDnpF8TMpicGRWNcE78NTbwDbcXBir8uTuA-jHdPYdiAy792WurpqSb1HiEsRrD__z_G-gYPp-ZczeTabn76AQ2rxGZMvobe6WdtXCJ1W5euwNH4C2GQYyA |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Ideation+and+assessment+of+a+nitric+oxide+delivery+system+for+spontaneously+breathing+subjects&rft.jtitle=Nitric+oxide&rft.au=Gianni%2C+Stefano&rft.au=Morais%2C+Caio+C+A&rft.au=Larson%2C+Grant&rft.au=Pinciroli%2C+Riccardo&rft.date=2020-11-01&rft.issn=1089-8611&rft.eissn=1089-8611&rft.volume=104-105&rft.spage=29&rft_id=info:doi/10.1016%2Fj.niox.2020.08.004&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1089-8603&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1089-8603&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1089-8603&client=summon |